Global Buprenorphine Patches Market Growth 2026-2032
The global Buprenorphine Patches market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Buprenorphine patches are a form of transdermal medication used primarily for pain management and, in some cases, for the treatment of opioid dependence. Buprenorphine is a partial opioid agonist, which means it activates opioid receptors in the brain but to a lesser extent than full agonists like morphine or heroin. This property makes it effective for pain relief while also reducing the risk of misuse and dependence.
United States market for Buprenorphine Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Buprenorphine Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Buprenorphine Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Buprenorphine Patches players cover Mundipharma, Gr?nenthal GmbH, Purdue Pharma, Teva Pharmaceuticals, Sandoz (a division of Novartis), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Buprenorphine Patches Industry Forecast” looks at past sales and reviews total world Buprenorphine Patches sales in 2025, providing a comprehensive analysis by region and market sector of projected Buprenorphine Patches sales for 2026 through 2032. With Buprenorphine Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buprenorphine Patches industry.
This Insight Report provides a comprehensive analysis of the global Buprenorphine Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buprenorphine Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Buprenorphine Patches market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buprenorphine Patches and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buprenorphine Patches.
This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Buprenorphine patches are a form of transdermal medication used primarily for pain management and, in some cases, for the treatment of opioid dependence. Buprenorphine is a partial opioid agonist, which means it activates opioid receptors in the brain but to a lesser extent than full agonists like morphine or heroin. This property makes it effective for pain relief while also reducing the risk of misuse and dependence.
United States market for Buprenorphine Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Buprenorphine Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Buprenorphine Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Buprenorphine Patches players cover Mundipharma, Gr?nenthal GmbH, Purdue Pharma, Teva Pharmaceuticals, Sandoz (a division of Novartis), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Buprenorphine Patches Industry Forecast” looks at past sales and reviews total world Buprenorphine Patches sales in 2025, providing a comprehensive analysis by region and market sector of projected Buprenorphine Patches sales for 2026 through 2032. With Buprenorphine Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buprenorphine Patches industry.
This Insight Report provides a comprehensive analysis of the global Buprenorphine Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buprenorphine Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Buprenorphine Patches market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buprenorphine Patches and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buprenorphine Patches.
This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- <10 Micrograms
- ?10 Micrograms
- Hospital
- Clinic
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mundipharma
- Gr?nenthal GmbH
- Purdue Pharma
- Teva Pharmaceuticals
- Sandoz (a division of Novartis)
- Camurus AB
- Endo Pharmaceuticals
- Pfizer
- Mylan (now part of Viatris)
- Indivior
- Hisamitsu Pharmaceutical Co., Inc.
- Alvogen
- What is the 10-year outlook for the global Buprenorphine Patches market?
- What factors are driving Buprenorphine Patches market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Buprenorphine Patches market opportunities vary by end market size?
- How does Buprenorphine Patches break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Buprenorphine Patches Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Buprenorphine Patches by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Buprenorphine Patches by Country/Region, 2021, 2025 & 2032
2.2 Buprenorphine Patches Segment by Type
2.2.1 <10 Micrograms
2.2.2 ?10 Micrograms
2.2.3 Buprenorphine Patches Sales by Type
2.2.3.1 Global Buprenorphine Patches Sales Market Share by Type (2021-2026)
2.2.3.2 Global Buprenorphine Patches Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Buprenorphine Patches Sale Price by Type (2021-2026)
2.3 Buprenorphine Patches Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Other
2.3.5 Buprenorphine Patches Sales by Application
2.3.5.1 Global Buprenorphine Patches Sale Market Share by Application (2021-2026)
2.3.5.2 Global Buprenorphine Patches Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Buprenorphine Patches Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Buprenorphine Patches Breakdown Data by Company
3.1.1 Global Buprenorphine Patches Annual Sales by Company (2021-2026)
3.1.2 Global Buprenorphine Patches Sales Market Share by Company (2021-2026)
3.2 Global Buprenorphine Patches Annual Revenue by Company (2021-2026)
3.2.1 Global Buprenorphine Patches Revenue by Company (2021-2026)
3.2.2 Global Buprenorphine Patches Revenue Market Share by Company (2021-2026)
3.3 Global Buprenorphine Patches Sale Price by Company
3.4 Key Manufacturers Buprenorphine Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Buprenorphine Patches Product Location Distribution
3.4.2 Players Buprenorphine Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BUPRENORPHINE PATCHES BY GEOGRAPHIC REGION
4.1 World Historic Buprenorphine Patches Market Size by Geographic Region (2021-2026)
4.1.1 Global Buprenorphine Patches Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Buprenorphine Patches Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Buprenorphine Patches Market Size by Country/Region (2021-2026)
4.2.1 Global Buprenorphine Patches Annual Sales by Country/Region (2021-2026)
4.2.2 Global Buprenorphine Patches Annual Revenue by Country/Region (2021-2026)
4.3 Americas Buprenorphine Patches Sales Growth
4.4 APAC Buprenorphine Patches Sales Growth
4.5 Europe Buprenorphine Patches Sales Growth
4.6 Middle East & Africa Buprenorphine Patches Sales Growth
5 AMERICAS
5.1 Americas Buprenorphine Patches Sales by Country
5.1.1 Americas Buprenorphine Patches Sales by Country (2021-2026)
5.1.2 Americas Buprenorphine Patches Revenue by Country (2021-2026)
5.2 Americas Buprenorphine Patches Sales by Type (2021-2026)
5.3 Americas Buprenorphine Patches Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Buprenorphine Patches Sales by Region
6.1.1 APAC Buprenorphine Patches Sales by Region (2021-2026)
6.1.2 APAC Buprenorphine Patches Revenue by Region (2021-2026)
6.2 APAC Buprenorphine Patches Sales by Type (2021-2026)
6.3 APAC Buprenorphine Patches Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Buprenorphine Patches by Country
7.1.1 Europe Buprenorphine Patches Sales by Country (2021-2026)
7.1.2 Europe Buprenorphine Patches Revenue by Country (2021-2026)
7.2 Europe Buprenorphine Patches Sales by Type (2021-2026)
7.3 Europe Buprenorphine Patches Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Buprenorphine Patches by Country
8.1.1 Middle East & Africa Buprenorphine Patches Sales by Country (2021-2026)
8.1.2 Middle East & Africa Buprenorphine Patches Revenue by Country (2021-2026)
8.2 Middle East & Africa Buprenorphine Patches Sales by Type (2021-2026)
8.3 Middle East & Africa Buprenorphine Patches Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Buprenorphine Patches
10.3 Manufacturing Process Analysis of Buprenorphine Patches
10.4 Industry Chain Structure of Buprenorphine Patches
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Buprenorphine Patches Distributors
11.3 Buprenorphine Patches Customer
12 WORLD FORECAST REVIEW FOR BUPRENORPHINE PATCHES BY GEOGRAPHIC REGION
12.1 Global Buprenorphine Patches Market Size Forecast by Region
12.1.1 Global Buprenorphine Patches Forecast by Region (2027-2032)
12.1.2 Global Buprenorphine Patches Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Buprenorphine Patches Forecast by Type (2027-2032)
12.7 Global Buprenorphine Patches Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Mundipharma
13.1.1 Mundipharma Company Information
13.1.2 Mundipharma Buprenorphine Patches Product Portfolios and Specifications
13.1.3 Mundipharma Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Mundipharma Main Business Overview
13.1.5 Mundipharma Latest Developments
13.2 Gr?nenthal GmbH
13.2.1 Gr?nenthal GmbH Company Information
13.2.2 Gr?nenthal GmbH Buprenorphine Patches Product Portfolios and Specifications
13.2.3 Gr?nenthal GmbH Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Gr?nenthal GmbH Main Business Overview
13.2.5 Gr?nenthal GmbH Latest Developments
13.3 Purdue Pharma
13.3.1 Purdue Pharma Company Information
13.3.2 Purdue Pharma Buprenorphine Patches Product Portfolios and Specifications
13.3.3 Purdue Pharma Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Purdue Pharma Main Business Overview
13.3.5 Purdue Pharma Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Sandoz (a division of Novartis)
13.5.1 Sandoz (a division of Novartis) Company Information
13.5.2 Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolios and Specifications
13.5.3 Sandoz (a division of Novartis) Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sandoz (a division of Novartis) Main Business Overview
13.5.5 Sandoz (a division of Novartis) Latest Developments
13.6 Camurus AB
13.6.1 Camurus AB Company Information
13.6.2 Camurus AB Buprenorphine Patches Product Portfolios and Specifications
13.6.3 Camurus AB Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Camurus AB Main Business Overview
13.6.5 Camurus AB Latest Developments
13.7 Endo Pharmaceuticals
13.7.1 Endo Pharmaceuticals Company Information
13.7.2 Endo Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
13.7.3 Endo Pharmaceuticals Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Endo Pharmaceuticals Main Business Overview
13.7.5 Endo Pharmaceuticals Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Buprenorphine Patches Product Portfolios and Specifications
13.8.3 Pfizer Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Mylan (now part of Viatris)
13.9.1 Mylan (now part of Viatris) Company Information
13.9.2 Mylan (now part of Viatris) Buprenorphine Patches Product Portfolios and Specifications
13.9.3 Mylan (now part of Viatris) Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mylan (now part of Viatris) Main Business Overview
13.9.5 Mylan (now part of Viatris) Latest Developments
13.10 Indivior
13.10.1 Indivior Company Information
13.10.2 Indivior Buprenorphine Patches Product Portfolios and Specifications
13.10.3 Indivior Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Indivior Main Business Overview
13.10.5 Indivior Latest Developments
13.11 Hisamitsu Pharmaceutical Co., Inc.
13.11.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
13.11.2 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolios and Specifications
13.11.3 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hisamitsu Pharmaceutical Co., Inc. Main Business Overview
13.11.5 Hisamitsu Pharmaceutical Co., Inc. Latest Developments
13.12 Alvogen
13.12.1 Alvogen Company Information
13.12.2 Alvogen Buprenorphine Patches Product Portfolios and Specifications
13.12.3 Alvogen Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Alvogen Main Business Overview
13.12.5 Alvogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Buprenorphine Patches Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Buprenorphine Patches by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Buprenorphine Patches by Country/Region, 2021, 2025 & 2032
2.2 Buprenorphine Patches Segment by Type
2.2.1 <10 Micrograms
2.2.2 ?10 Micrograms
2.2.3 Buprenorphine Patches Sales by Type
2.2.3.1 Global Buprenorphine Patches Sales Market Share by Type (2021-2026)
2.2.3.2 Global Buprenorphine Patches Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Buprenorphine Patches Sale Price by Type (2021-2026)
2.3 Buprenorphine Patches Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Other
2.3.5 Buprenorphine Patches Sales by Application
2.3.5.1 Global Buprenorphine Patches Sale Market Share by Application (2021-2026)
2.3.5.2 Global Buprenorphine Patches Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Buprenorphine Patches Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Buprenorphine Patches Breakdown Data by Company
3.1.1 Global Buprenorphine Patches Annual Sales by Company (2021-2026)
3.1.2 Global Buprenorphine Patches Sales Market Share by Company (2021-2026)
3.2 Global Buprenorphine Patches Annual Revenue by Company (2021-2026)
3.2.1 Global Buprenorphine Patches Revenue by Company (2021-2026)
3.2.2 Global Buprenorphine Patches Revenue Market Share by Company (2021-2026)
3.3 Global Buprenorphine Patches Sale Price by Company
3.4 Key Manufacturers Buprenorphine Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Buprenorphine Patches Product Location Distribution
3.4.2 Players Buprenorphine Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BUPRENORPHINE PATCHES BY GEOGRAPHIC REGION
4.1 World Historic Buprenorphine Patches Market Size by Geographic Region (2021-2026)
4.1.1 Global Buprenorphine Patches Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Buprenorphine Patches Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Buprenorphine Patches Market Size by Country/Region (2021-2026)
4.2.1 Global Buprenorphine Patches Annual Sales by Country/Region (2021-2026)
4.2.2 Global Buprenorphine Patches Annual Revenue by Country/Region (2021-2026)
4.3 Americas Buprenorphine Patches Sales Growth
4.4 APAC Buprenorphine Patches Sales Growth
4.5 Europe Buprenorphine Patches Sales Growth
4.6 Middle East & Africa Buprenorphine Patches Sales Growth
5 AMERICAS
5.1 Americas Buprenorphine Patches Sales by Country
5.1.1 Americas Buprenorphine Patches Sales by Country (2021-2026)
5.1.2 Americas Buprenorphine Patches Revenue by Country (2021-2026)
5.2 Americas Buprenorphine Patches Sales by Type (2021-2026)
5.3 Americas Buprenorphine Patches Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Buprenorphine Patches Sales by Region
6.1.1 APAC Buprenorphine Patches Sales by Region (2021-2026)
6.1.2 APAC Buprenorphine Patches Revenue by Region (2021-2026)
6.2 APAC Buprenorphine Patches Sales by Type (2021-2026)
6.3 APAC Buprenorphine Patches Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Buprenorphine Patches by Country
7.1.1 Europe Buprenorphine Patches Sales by Country (2021-2026)
7.1.2 Europe Buprenorphine Patches Revenue by Country (2021-2026)
7.2 Europe Buprenorphine Patches Sales by Type (2021-2026)
7.3 Europe Buprenorphine Patches Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Buprenorphine Patches by Country
8.1.1 Middle East & Africa Buprenorphine Patches Sales by Country (2021-2026)
8.1.2 Middle East & Africa Buprenorphine Patches Revenue by Country (2021-2026)
8.2 Middle East & Africa Buprenorphine Patches Sales by Type (2021-2026)
8.3 Middle East & Africa Buprenorphine Patches Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Buprenorphine Patches
10.3 Manufacturing Process Analysis of Buprenorphine Patches
10.4 Industry Chain Structure of Buprenorphine Patches
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Buprenorphine Patches Distributors
11.3 Buprenorphine Patches Customer
12 WORLD FORECAST REVIEW FOR BUPRENORPHINE PATCHES BY GEOGRAPHIC REGION
12.1 Global Buprenorphine Patches Market Size Forecast by Region
12.1.1 Global Buprenorphine Patches Forecast by Region (2027-2032)
12.1.2 Global Buprenorphine Patches Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Buprenorphine Patches Forecast by Type (2027-2032)
12.7 Global Buprenorphine Patches Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Mundipharma
13.1.1 Mundipharma Company Information
13.1.2 Mundipharma Buprenorphine Patches Product Portfolios and Specifications
13.1.3 Mundipharma Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Mundipharma Main Business Overview
13.1.5 Mundipharma Latest Developments
13.2 Gr?nenthal GmbH
13.2.1 Gr?nenthal GmbH Company Information
13.2.2 Gr?nenthal GmbH Buprenorphine Patches Product Portfolios and Specifications
13.2.3 Gr?nenthal GmbH Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Gr?nenthal GmbH Main Business Overview
13.2.5 Gr?nenthal GmbH Latest Developments
13.3 Purdue Pharma
13.3.1 Purdue Pharma Company Information
13.3.2 Purdue Pharma Buprenorphine Patches Product Portfolios and Specifications
13.3.3 Purdue Pharma Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Purdue Pharma Main Business Overview
13.3.5 Purdue Pharma Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Sandoz (a division of Novartis)
13.5.1 Sandoz (a division of Novartis) Company Information
13.5.2 Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolios and Specifications
13.5.3 Sandoz (a division of Novartis) Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sandoz (a division of Novartis) Main Business Overview
13.5.5 Sandoz (a division of Novartis) Latest Developments
13.6 Camurus AB
13.6.1 Camurus AB Company Information
13.6.2 Camurus AB Buprenorphine Patches Product Portfolios and Specifications
13.6.3 Camurus AB Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Camurus AB Main Business Overview
13.6.5 Camurus AB Latest Developments
13.7 Endo Pharmaceuticals
13.7.1 Endo Pharmaceuticals Company Information
13.7.2 Endo Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
13.7.3 Endo Pharmaceuticals Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Endo Pharmaceuticals Main Business Overview
13.7.5 Endo Pharmaceuticals Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Buprenorphine Patches Product Portfolios and Specifications
13.8.3 Pfizer Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Mylan (now part of Viatris)
13.9.1 Mylan (now part of Viatris) Company Information
13.9.2 Mylan (now part of Viatris) Buprenorphine Patches Product Portfolios and Specifications
13.9.3 Mylan (now part of Viatris) Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mylan (now part of Viatris) Main Business Overview
13.9.5 Mylan (now part of Viatris) Latest Developments
13.10 Indivior
13.10.1 Indivior Company Information
13.10.2 Indivior Buprenorphine Patches Product Portfolios and Specifications
13.10.3 Indivior Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Indivior Main Business Overview
13.10.5 Indivior Latest Developments
13.11 Hisamitsu Pharmaceutical Co., Inc.
13.11.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
13.11.2 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolios and Specifications
13.11.3 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hisamitsu Pharmaceutical Co., Inc. Main Business Overview
13.11.5 Hisamitsu Pharmaceutical Co., Inc. Latest Developments
13.12 Alvogen
13.12.1 Alvogen Company Information
13.12.2 Alvogen Buprenorphine Patches Product Portfolios and Specifications
13.12.3 Alvogen Buprenorphine Patches Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Alvogen Main Business Overview
13.12.5 Alvogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Buprenorphine Patches Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Buprenorphine Patches Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of <10 Micrograms
Table 4. Major Players of ?10 Micrograms
Table 5. Global Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 6. Global Buprenorphine Patches Sales Market Share by Type (2021-2026)
Table 7. Global Buprenorphine Patches Revenue by Type (2021-2026) & ($ million)
Table 8. Global Buprenorphine Patches Revenue Market Share by Type (2021-2026)
Table 9. Global Buprenorphine Patches Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Buprenorphine Patches Sale by Application (2021-2026) & (K Units)
Table 11. Global Buprenorphine Patches Sale Market Share by Application (2021-2026)
Table 12. Global Buprenorphine Patches Revenue by Application (2021-2026) & ($ million)
Table 13. Global Buprenorphine Patches Revenue Market Share by Application (2021-2026)
Table 14. Global Buprenorphine Patches Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Buprenorphine Patches Sales by Company (2021-2026) & (K Units)
Table 16. Global Buprenorphine Patches Sales Market Share by Company (2021-2026)
Table 17. Global Buprenorphine Patches Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Buprenorphine Patches Revenue Market Share by Company (2021-2026)
Table 19. Global Buprenorphine Patches Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Buprenorphine Patches Producing Area Distribution and Sales Area
Table 21. Players Buprenorphine Patches Products Offered
Table 22. Buprenorphine Patches Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Buprenorphine Patches Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Buprenorphine Patches Sales Market Share Geographic Region (2021-2026)
Table 27. Global Buprenorphine Patches Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Buprenorphine Patches Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Buprenorphine Patches Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Buprenorphine Patches Sales Market Share by Country/Region (2021-2026)
Table 31. Global Buprenorphine Patches Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Buprenorphine Patches Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Buprenorphine Patches Sales by Country (2021-2026) & (K Units)
Table 34. Americas Buprenorphine Patches Sales Market Share by Country (2021-2026)
Table 35. Americas Buprenorphine Patches Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 37. Americas Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 38. APAC Buprenorphine Patches Sales by Region (2021-2026) & (K Units)
Table 39. APAC Buprenorphine Patches Sales Market Share by Region (2021-2026)
Table 40. APAC Buprenorphine Patches Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 42. APAC Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 43. Europe Buprenorphine Patches Sales by Country (2021-2026) & (K Units)
Table 44. Europe Buprenorphine Patches Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 46. Europe Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Buprenorphine Patches Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Buprenorphine Patches Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Buprenorphine Patches
Table 52. Key Market Challenges & Risks of Buprenorphine Patches
Table 53. Key Industry Trends of Buprenorphine Patches
Table 54. Buprenorphine Patches Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Buprenorphine Patches Distributors List
Table 57. Buprenorphine Patches Customer List
Table 58. Global Buprenorphine Patches Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Buprenorphine Patches Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Buprenorphine Patches Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Buprenorphine Patches Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Buprenorphine Patches Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Buprenorphine Patches Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Buprenorphine Patches Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Buprenorphine Patches Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Buprenorphine Patches Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Buprenorphine Patches Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Buprenorphine Patches Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Buprenorphine Patches Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Buprenorphine Patches Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Buprenorphine Patches Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Mundipharma Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 73. Mundipharma Buprenorphine Patches Product Portfolios and Specifications
Table 74. Mundipharma Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Mundipharma Main Business
Table 76. Mundipharma Latest Developments
Table 77. Gr?nenthal GmbH Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 78. Gr?nenthal GmbH Buprenorphine Patches Product Portfolios and Specifications
Table 79. Gr?nenthal GmbH Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Gr?nenthal GmbH Main Business
Table 81. Gr?nenthal GmbH Latest Developments
Table 82. Purdue Pharma Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 83. Purdue Pharma Buprenorphine Patches Product Portfolios and Specifications
Table 84. Purdue Pharma Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Purdue Pharma Main Business
Table 86. Purdue Pharma Latest Developments
Table 87. Teva Pharmaceuticals Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
Table 89. Teva Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Teva Pharmaceuticals Main Business
Table 91. Teva Pharmaceuticals Latest Developments
Table 92. Sandoz (a division of Novartis) Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 93. Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolios and Specifications
Table 94. Sandoz (a division of Novartis) Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sandoz (a division of Novartis) Main Business
Table 96. Sandoz (a division of Novartis) Latest Developments
Table 97. Camurus AB Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 98. Camurus AB Buprenorphine Patches Product Portfolios and Specifications
Table 99. Camurus AB Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Camurus AB Main Business
Table 101. Camurus AB Latest Developments
Table 102. Endo Pharmaceuticals Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 103. Endo Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
Table 104. Endo Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Endo Pharmaceuticals Main Business
Table 106. Endo Pharmaceuticals Latest Developments
Table 107. Pfizer Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Buprenorphine Patches Product Portfolios and Specifications
Table 109. Pfizer Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Mylan (now part of Viatris) Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan (now part of Viatris) Buprenorphine Patches Product Portfolios and Specifications
Table 114. Mylan (now part of Viatris) Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Mylan (now part of Viatris) Main Business
Table 116. Mylan (now part of Viatris) Latest Developments
Table 117. Indivior Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 118. Indivior Buprenorphine Patches Product Portfolios and Specifications
Table 119. Indivior Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Indivior Main Business
Table 121. Indivior Latest Developments
Table 122. Hisamitsu Pharmaceutical Co., Inc. Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 123. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolios and Specifications
Table 124. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Hisamitsu Pharmaceutical Co., Inc. Main Business
Table 126. Hisamitsu Pharmaceutical Co., Inc. Latest Developments
Table 127. Alvogen Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 128. Alvogen Buprenorphine Patches Product Portfolios and Specifications
Table 129. Alvogen Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Alvogen Main Business
Table 131. Alvogen Latest Developments
Table 1. Buprenorphine Patches Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Buprenorphine Patches Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of <10 Micrograms
Table 4. Major Players of ?10 Micrograms
Table 5. Global Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 6. Global Buprenorphine Patches Sales Market Share by Type (2021-2026)
Table 7. Global Buprenorphine Patches Revenue by Type (2021-2026) & ($ million)
Table 8. Global Buprenorphine Patches Revenue Market Share by Type (2021-2026)
Table 9. Global Buprenorphine Patches Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Buprenorphine Patches Sale by Application (2021-2026) & (K Units)
Table 11. Global Buprenorphine Patches Sale Market Share by Application (2021-2026)
Table 12. Global Buprenorphine Patches Revenue by Application (2021-2026) & ($ million)
Table 13. Global Buprenorphine Patches Revenue Market Share by Application (2021-2026)
Table 14. Global Buprenorphine Patches Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Buprenorphine Patches Sales by Company (2021-2026) & (K Units)
Table 16. Global Buprenorphine Patches Sales Market Share by Company (2021-2026)
Table 17. Global Buprenorphine Patches Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Buprenorphine Patches Revenue Market Share by Company (2021-2026)
Table 19. Global Buprenorphine Patches Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Buprenorphine Patches Producing Area Distribution and Sales Area
Table 21. Players Buprenorphine Patches Products Offered
Table 22. Buprenorphine Patches Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Buprenorphine Patches Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Buprenorphine Patches Sales Market Share Geographic Region (2021-2026)
Table 27. Global Buprenorphine Patches Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Buprenorphine Patches Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Buprenorphine Patches Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Buprenorphine Patches Sales Market Share by Country/Region (2021-2026)
Table 31. Global Buprenorphine Patches Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Buprenorphine Patches Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Buprenorphine Patches Sales by Country (2021-2026) & (K Units)
Table 34. Americas Buprenorphine Patches Sales Market Share by Country (2021-2026)
Table 35. Americas Buprenorphine Patches Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 37. Americas Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 38. APAC Buprenorphine Patches Sales by Region (2021-2026) & (K Units)
Table 39. APAC Buprenorphine Patches Sales Market Share by Region (2021-2026)
Table 40. APAC Buprenorphine Patches Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 42. APAC Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 43. Europe Buprenorphine Patches Sales by Country (2021-2026) & (K Units)
Table 44. Europe Buprenorphine Patches Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 46. Europe Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Buprenorphine Patches Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Buprenorphine Patches Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Buprenorphine Patches Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Buprenorphine Patches Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Buprenorphine Patches
Table 52. Key Market Challenges & Risks of Buprenorphine Patches
Table 53. Key Industry Trends of Buprenorphine Patches
Table 54. Buprenorphine Patches Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Buprenorphine Patches Distributors List
Table 57. Buprenorphine Patches Customer List
Table 58. Global Buprenorphine Patches Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Buprenorphine Patches Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Buprenorphine Patches Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Buprenorphine Patches Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Buprenorphine Patches Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Buprenorphine Patches Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Buprenorphine Patches Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Buprenorphine Patches Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Buprenorphine Patches Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Buprenorphine Patches Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Buprenorphine Patches Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Buprenorphine Patches Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Buprenorphine Patches Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Buprenorphine Patches Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Mundipharma Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 73. Mundipharma Buprenorphine Patches Product Portfolios and Specifications
Table 74. Mundipharma Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Mundipharma Main Business
Table 76. Mundipharma Latest Developments
Table 77. Gr?nenthal GmbH Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 78. Gr?nenthal GmbH Buprenorphine Patches Product Portfolios and Specifications
Table 79. Gr?nenthal GmbH Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Gr?nenthal GmbH Main Business
Table 81. Gr?nenthal GmbH Latest Developments
Table 82. Purdue Pharma Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 83. Purdue Pharma Buprenorphine Patches Product Portfolios and Specifications
Table 84. Purdue Pharma Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Purdue Pharma Main Business
Table 86. Purdue Pharma Latest Developments
Table 87. Teva Pharmaceuticals Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
Table 89. Teva Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Teva Pharmaceuticals Main Business
Table 91. Teva Pharmaceuticals Latest Developments
Table 92. Sandoz (a division of Novartis) Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 93. Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolios and Specifications
Table 94. Sandoz (a division of Novartis) Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sandoz (a division of Novartis) Main Business
Table 96. Sandoz (a division of Novartis) Latest Developments
Table 97. Camurus AB Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 98. Camurus AB Buprenorphine Patches Product Portfolios and Specifications
Table 99. Camurus AB Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Camurus AB Main Business
Table 101. Camurus AB Latest Developments
Table 102. Endo Pharmaceuticals Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 103. Endo Pharmaceuticals Buprenorphine Patches Product Portfolios and Specifications
Table 104. Endo Pharmaceuticals Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Endo Pharmaceuticals Main Business
Table 106. Endo Pharmaceuticals Latest Developments
Table 107. Pfizer Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Buprenorphine Patches Product Portfolios and Specifications
Table 109. Pfizer Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Mylan (now part of Viatris) Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan (now part of Viatris) Buprenorphine Patches Product Portfolios and Specifications
Table 114. Mylan (now part of Viatris) Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Mylan (now part of Viatris) Main Business
Table 116. Mylan (now part of Viatris) Latest Developments
Table 117. Indivior Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 118. Indivior Buprenorphine Patches Product Portfolios and Specifications
Table 119. Indivior Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Indivior Main Business
Table 121. Indivior Latest Developments
Table 122. Hisamitsu Pharmaceutical Co., Inc. Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 123. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolios and Specifications
Table 124. Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Hisamitsu Pharmaceutical Co., Inc. Main Business
Table 126. Hisamitsu Pharmaceutical Co., Inc. Latest Developments
Table 127. Alvogen Basic Information, Buprenorphine Patches Manufacturing Base, Sales Area and Its Competitors
Table 128. Alvogen Buprenorphine Patches Product Portfolios and Specifications
Table 129. Alvogen Buprenorphine Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Alvogen Main Business
Table 131. Alvogen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Buprenorphine Patches
Figure 2. Buprenorphine Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Buprenorphine Patches Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Buprenorphine Patches Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Buprenorphine Patches Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Buprenorphine Patches Sales Market Share by Country/Region (2025)
Figure 10. Buprenorphine Patches Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of <10 Micrograms
Figure 12. Product Picture of ?10 Micrograms
Figure 13. Global Buprenorphine Patches Sales Market Share by Type in 2026
Figure 14. Global Buprenorphine Patches Revenue Market Share by Type (2021-2026)
Figure 15. Buprenorphine Patches Consumed in Hospital
Figure 16. Global Buprenorphine Patches Market: Hospital (2021-2026) & (K Units)
Figure 17. Buprenorphine Patches Consumed in Clinic
Figure 18. Global Buprenorphine Patches Market: Clinic (2021-2026) & (K Units)
Figure 19. Buprenorphine Patches Consumed in Pharmacy
Figure 20. Global Buprenorphine Patches Market: Pharmacy (2021-2026) & (K Units)
Figure 21. Buprenorphine Patches Consumed in Other
Figure 22. Global Buprenorphine Patches Market: Other (2021-2026) & (K Units)
Figure 23. Global Buprenorphine Patches Sale Market Share by Application (2025)
Figure 24. Global Buprenorphine Patches Revenue Market Share by Application in 2026
Figure 25. Buprenorphine Patches Sales by Company in 2026 (K Units)
Figure 26. Global Buprenorphine Patches Sales Market Share by Company in 2026
Figure 27. Buprenorphine Patches Revenue by Company in 2026 ($ millions)
Figure 28. Global Buprenorphine Patches Revenue Market Share by Company in 2026
Figure 29. Global Buprenorphine Patches Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Buprenorphine Patches Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 32. Americas Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 33. APAC Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 34. APAC Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 35. Europe Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 36. Europe Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 39. Americas Buprenorphine Patches Sales Market Share by Country in 2026
Figure 40. Americas Buprenorphine Patches Revenue Market Share by Country (2021-2026)
Figure 41. Americas Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 42. Americas Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 43. United States Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Buprenorphine Patches Sales Market Share by Region in 2026
Figure 48. APAC Buprenorphine Patches Revenue Market Share by Region (2021-2026)
Figure 49. APAC Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 50. APAC Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 51. China Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 55. India Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Buprenorphine Patches Sales Market Share by Country in 2026
Figure 59. Europe Buprenorphine Patches Revenue Market Share by Country (2021-2026)
Figure 60. Europe Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 61. Europe Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 62. Germany Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 63. France Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Buprenorphine Patches Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 70. Egypt Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Buprenorphine Patches in 2026
Figure 76. Manufacturing Process Analysis of Buprenorphine Patches
Figure 77. Industry Chain Structure of Buprenorphine Patches
Figure 78. Channels of Distribution
Figure 79. Global Buprenorphine Patches Sales Market Forecast by Region (2027-2032)
Figure 80. Global Buprenorphine Patches Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Buprenorphine Patches Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Buprenorphine Patches Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Buprenorphine Patches Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Buprenorphine Patches Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Buprenorphine Patches
Figure 2. Buprenorphine Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Buprenorphine Patches Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Buprenorphine Patches Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Buprenorphine Patches Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Buprenorphine Patches Sales Market Share by Country/Region (2025)
Figure 10. Buprenorphine Patches Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of <10 Micrograms
Figure 12. Product Picture of ?10 Micrograms
Figure 13. Global Buprenorphine Patches Sales Market Share by Type in 2026
Figure 14. Global Buprenorphine Patches Revenue Market Share by Type (2021-2026)
Figure 15. Buprenorphine Patches Consumed in Hospital
Figure 16. Global Buprenorphine Patches Market: Hospital (2021-2026) & (K Units)
Figure 17. Buprenorphine Patches Consumed in Clinic
Figure 18. Global Buprenorphine Patches Market: Clinic (2021-2026) & (K Units)
Figure 19. Buprenorphine Patches Consumed in Pharmacy
Figure 20. Global Buprenorphine Patches Market: Pharmacy (2021-2026) & (K Units)
Figure 21. Buprenorphine Patches Consumed in Other
Figure 22. Global Buprenorphine Patches Market: Other (2021-2026) & (K Units)
Figure 23. Global Buprenorphine Patches Sale Market Share by Application (2025)
Figure 24. Global Buprenorphine Patches Revenue Market Share by Application in 2026
Figure 25. Buprenorphine Patches Sales by Company in 2026 (K Units)
Figure 26. Global Buprenorphine Patches Sales Market Share by Company in 2026
Figure 27. Buprenorphine Patches Revenue by Company in 2026 ($ millions)
Figure 28. Global Buprenorphine Patches Revenue Market Share by Company in 2026
Figure 29. Global Buprenorphine Patches Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Buprenorphine Patches Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 32. Americas Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 33. APAC Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 34. APAC Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 35. Europe Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 36. Europe Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Buprenorphine Patches Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Buprenorphine Patches Revenue 2021-2026 ($ millions)
Figure 39. Americas Buprenorphine Patches Sales Market Share by Country in 2026
Figure 40. Americas Buprenorphine Patches Revenue Market Share by Country (2021-2026)
Figure 41. Americas Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 42. Americas Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 43. United States Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Buprenorphine Patches Sales Market Share by Region in 2026
Figure 48. APAC Buprenorphine Patches Revenue Market Share by Region (2021-2026)
Figure 49. APAC Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 50. APAC Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 51. China Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 55. India Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Buprenorphine Patches Sales Market Share by Country in 2026
Figure 59. Europe Buprenorphine Patches Revenue Market Share by Country (2021-2026)
Figure 60. Europe Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 61. Europe Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 62. Germany Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 63. France Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Buprenorphine Patches Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Buprenorphine Patches Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Buprenorphine Patches Sales Market Share by Application (2021-2026)
Figure 70. Egypt Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Buprenorphine Patches Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Buprenorphine Patches in 2026
Figure 76. Manufacturing Process Analysis of Buprenorphine Patches
Figure 77. Industry Chain Structure of Buprenorphine Patches
Figure 78. Channels of Distribution
Figure 79. Global Buprenorphine Patches Sales Market Forecast by Region (2027-2032)
Figure 80. Global Buprenorphine Patches Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Buprenorphine Patches Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Buprenorphine Patches Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Buprenorphine Patches Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Buprenorphine Patches Revenue Market Share Forecast by Application (2027-2032)
